296 related articles for article (PubMed ID: 18674905)
1. Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
Shiraishi T; Kadono S; Haramura M; Kodama H; Ono Y; Iikura H; Esaki T; Koga T; Hattori K; Watanabe Y; Sakamoto A; Yoshihashi K; Kitazawa T; Esaki K; Ohta M; Sato H; Kozono T
Bioorg Med Chem Lett; 2008 Aug; 18(16):4533-7. PubMed ID: 18674905
[TBL] [Abstract][Full Text] [Related]
2. Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-Eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2005 Jan; 326(4):859-65. PubMed ID: 15607748
[TBL] [Abstract][Full Text] [Related]
3. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
[TBL] [Abstract][Full Text] [Related]
4. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
[TBL] [Abstract][Full Text] [Related]
5. Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores.
Kotian PL; Krishnan R; Rowland S; El-Kattan Y; Saini SK; Upshaw R; Bantia S; Arnold S; Babu YS; Chand P
Bioorg Med Chem; 2009 Jun; 17(11):3934-58. PubMed ID: 19409795
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2005 Feb; 327(2):589-96. PubMed ID: 15629154
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of Factor VIIa/tissue factor.
Shirk RA; Vlasuk GP
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
[TBL] [Abstract][Full Text] [Related]
8. Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.
Zbinden KG; Obst-Sander U; Hilpert K; Kühne H; Banner DW; Böhm HJ; Stahl M; Ackermann J; Alig L; Weber L; Wessel HP; Riederer MA; Tschopp TB; Lavé T
Bioorg Med Chem Lett; 2005 Dec; 15(23):5344-52. PubMed ID: 16213138
[TBL] [Abstract][Full Text] [Related]
9. Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors.
Groebke Zbinden K; Banner DW; Ackermann J; D'Arcy A; Kirchhofer D; Ji YH; Tschopp TB; Wallbaum S; Weber L
Bioorg Med Chem Lett; 2005 Feb; 15(3):817-22. PubMed ID: 15664864
[TBL] [Abstract][Full Text] [Related]
10. Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.
Sagi K; Fujita K; Sugiki M; Takahashi M; Takehana S; Tashiro K; Kayahara T; Yamanashi M; Fukuda Y; Oono S; Okajima A; Iwata S; Shoji M; Sakurai K
Bioorg Med Chem; 2005 Mar; 13(5):1487-96. PubMed ID: 15698764
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors.
Parlow JJ; Kurumbail RG; Stegeman RA; Stevens AM; Stallings WC; South MS
J Med Chem; 2003 Oct; 46(22):4696-701. PubMed ID: 14561089
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors.
Glunz PW; Cheng X; Cheney DL; Weigelt CA; Wei A; Luettgen JM; Wong PC; Wexler RR; Priestley ES
Bioorg Med Chem Lett; 2015; 25(10):2169-73. PubMed ID: 25881820
[TBL] [Abstract][Full Text] [Related]
13. Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.
Young WB; Mordenti J; Torkelson S; Shrader WD; Kolesnikov A; Rai R; Liu L; Hu H; Leahy EM; Green MJ; Sprengeler PA; Katz BA; Yu C; Janc JW; Elrod KC; Marzec UM; Hanson SR
Bioorg Med Chem Lett; 2006 Apr; 16(7):2037-41. PubMed ID: 16412633
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in serine protease inhibitors as anticoagulant agents.
Prezelj A; Anderluh PS; Peternel L; Urleb U
Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
[TBL] [Abstract][Full Text] [Related]
15. Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors.
Glunz PW; Zhang X; Zou Y; Delucca I; Nirschl AH; Cheng X; Weigelt CA; Cheney DL; Wei A; Anumula R; Luettgen JM; Rendina AR; Harpel M; Luo G; Knabb R; Wong PC; Wexler RR; Priestley ES
Bioorg Med Chem Lett; 2013 Sep; 23(18):5244-8. PubMed ID: 23845220
[TBL] [Abstract][Full Text] [Related]
16. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
Wang G; Goyal N; Hopkinson B
Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
[TBL] [Abstract][Full Text] [Related]
17. Peptide exosite inhibitors of factor VIIa as anticoagulants.
Dennis MS; Eigenbrot C; Skelton NJ; Ultsch MH; Santell L; Dwyer MA; O'Connell MP; Lazarus RA
Nature; 2000 Mar; 404(6777):465-70. PubMed ID: 10761907
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors.
Priestley ES; Cheney DL; DeLucca I; Wei A; Luettgen JM; Rendina AR; Wong PC; Wexler RR
J Med Chem; 2015 Aug; 58(15):6225-36. PubMed ID: 26151189
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided design of peptide-based tryptase inhibitors.
McGrath ME; Sprengeler PA; Hirschbein B; Somoza JR; Lehoux I; Janc JW; Gjerstad E; Graupe M; Estiarte A; Venkataramani C; Liu Y; Yee R; Ho JD; Green MJ; Lee CS; Liu L; Tai V; Spencer J; Sperandio D; Katz BA
Biochemistry; 2006 May; 45(19):5964-73. PubMed ID: 16681368
[TBL] [Abstract][Full Text] [Related]
20. Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors.
Buckman BO; Chou YL; McCarrick M; Liang A; Lentz D; Mohan R; Morrissey MM; Shaw KJ; Trinh L; Light DR
Bioorg Med Chem Lett; 2005 May; 15(9):2249-52. PubMed ID: 15837303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
